Pricing Log in Create free account

LianBio Sponsored ADR (LIANY) vs Pelthos Therapeutics Inc. (PTHS)

LianBio Sponsored ADR and Pelthos Therapeutics Inc. are both Biotechnology companies. LianBio Sponsored ADR and Pelthos Therapeutics Inc. are of similar size ($35.6M and $34.2M). Pelthos Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; LianBio Sponsored ADR trades at 0.0×. LianBio Sponsored ADR has the higher net margin (0.00% vs −199.5%) and the lower return on invested capital (−450.5% vs −82.3%). Across the 13 metrics below, LianBio Sponsored ADR leads on 8 and Pelthos Therapeutics Inc. on 5.

Valuation

Metric LIANY PTHS Biotechnology median
P/E 0.01 n/m 10.60
P/S n/m 0.78 9.40
P/B 0.01 n/m 2.13
Price to free cash flow 0.02 n/m 25.18
EV/EBITDA 5.73 n/m 0.66
EV/Sales n/m 1.88 9.02
Earnings yield 7,216.75% (276.23%) (32.88%)
Free cash flow yield 5,994.86% (126.55%) (23.13%)

Profitability

Metric LIANY PTHS Biotechnology median
Gross margin 0.00% 78.59% 68.51%
Operating margin 0.00% (133.42%) 0.00%
Net margin 0.00% (199.50%) 0.00%
Free cash flow margin 0.00% (98.37%) 0.00%
Return on equity 70.96% 2,161.07% (51.96%)
Return on assets 66.19% (125.04%) (46.06%)
Return on invested capital (450.47%) (82.34%) 0.00%

Growth

Metric LIANY PTHS Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 75.44% (61.12%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric LIANY PTHS Biotechnology median
Debt to equity 0.00 (46.58) 0.00
Current ratio 17.03 1.98 4.97
Net debt to EBITDA 7.41 (0.45) 1.01

Dividend

Metric LIANY PTHS Biotechnology median
Dividend yield 0.00% — 0.41%
Payout ratio — — —

Size

Metric LIANY PTHS Biotechnology median
Market cap 34.19m 35.61m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack